Need to confirm isoniazid susceptibility in xpert MTB/RIF rifampin susceptible cases

Indian Journal of Medical Research

Volumn 135, Issue 4, 2012, Pages 560-561

  Vadwai, Viral ^a   Boehme, Catharina ^b   Nabeta, Pamela ^b   Shetty, Anjali ^a   Rodrigues, Camilla ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

^b FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

AEROSOL; ANTIBIOTIC SENSITIVITY; ARTICLE; DIAGNOSTIC TEST; EXTRAPULMONARY TUBERCULOSIS; HUMAN; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PREVALENCE; SPUTUM;

ANTIBIOTICS, ANTITUBERCULAR; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION;

EID: 84861953374     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
2. Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol 2011; 49: 2540-2545.
3. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-1505.
4. World Health Organization. Rapid implementation of the Xpert MTB/RIF diagnostic test technical and operational 'How-to' Practical considerations. WHO/HTM/TB/2011.2. Geneva: World Health Organization; 2011.
5. D'souza D, Mistry NF, Vira TS, Dholakia Y, Hoffner S, Pasvol G, et al. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India. BMC Public Health 2009; 9: 211.
6. Cattamanchi A, Dantes RB, Metcalfe JZ, Jarlsberg LG, Grinsdale J, Kawamura LM, et al. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin Infect Dis 2009; 48: 179-185.